Sinew Pharma, Inc. Statistics
Sinew Pharma, Inc. (6634) Stock Statistics & Valuation Metrics
Total Valuation
Sinew Pharma, Inc. has a market cap or net worth of TWD 4.08B. The enterprise value is ―.
- Market Cap
- TWD 4.08B
- Enterprise Value
- ―
Share Statistics
Sinew Pharma, Inc. has 71,285,250 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 71,285,250
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Sinew Pharma, Inc.’s return on equity (ROE) is -0.11 and return on invested capital (ROIC) is -12.65%.
- Return on Equity (ROE)
- -0.11
- Return on Assets (ROA)
- -0.11
- Return on Invested Capital (ROIC)
- -12.65%
- Return on Capital Employed (ROCE)
- -0.13
- Revenue Per Employee
- 903.846
- Profits Per Employee
- -2.38M
- Employee Count
- 52
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Sinew Pharma, Inc. is -36.45. Sinew Pharma, Inc.’s PEG ratio is -2.05.
- PE Ratio
- -36.45
- PS Ratio
- 91760.80
- PB Ratio
- 4.15
- Price to FCF
- -43.86
- Price to Operating Cash Flow
- -44.07
- PEG Ratio
- -2.05
Income Statement
In the last 12 months, Sinew Pharma, Inc. had revenue of 47.00K and earned -123.75M in profits. Earnings per share was -1.74.
- Revenue
- 47.00K
- Gross Profit
- -19.29M
- Operating Income
- -140.13M
- Pretax Income
- -123.75M
- Net Income
- -123.75M
- EBITDA
- -120.80M
- Earnings Per Share (EPS)
- -1.74
Cash Flow
In the last 12 months, operating cash flow was -97.67M and capital expenditures -658,000, giving a free cash flow of -98.33M billion.
- Operating Cash Flow
- -97.67M
- Free Cash Flow
- -98.33M
- Free Cash Flow per Share
- -1.38
Dividends & Yields
Sinew Pharma, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -2.18%
- Earnings Yield
- -2.63%
Stock Price Statistics
- Beta
- 0.42
- 52-Week Price Change
- 53.58%
- 50-Day Moving Average
- ―
- 200-Day Moving Average
- ―
- Relative Strength Index (RSI)
- 49.75
- Average Volume (3m)
- 97.79K
Financial Position
Sinew Pharma, Inc. as a current ratio of 42.27, with Debt / Equity ratio of 1.39%
- Current Ratio
- 42.27
- Quick Ratio
- 42.27
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 0.08
- Interest Coverage Ratio
- -213.28
Taxes
In the past 12 months, Sinew Pharma, Inc. has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Sinew Pharma, Inc. EV to EBITDA ratio is -36.92, with an EV/FCF ratio of -45.61.
- EV to Sales
- 95423.76
- EV to EBITDA
- -36.92
- EV to Free Cash Flow
- -45.61
- EV to Operating Cash Flow
- -45.92
Balance Sheet
Sinew Pharma, Inc. has TWD 995.27M in cash and marketable securities with TWD 12.27M in debt, giving a net cash position of TWD 983.00M billion.
- Cash & Marketable Securities
- TWD 995.27M
- Total Debt
- TWD 12.27M
- Net Cash
- TWD 983.00M
- Net Cash Per Share
- TWD 13.79
- Tangible Book Value Per Share
- TWD 14.38
Margins
Gross margin is -24610.64%, with operating margin of -283142.55%, and net profit margin of -251980.85%.
- Gross Margin
- -24610.64%
- Operating Margin
- -283142.55%
- Pretax Margin
- -251980.85%
- Net Profit Margin
- -251980.85%
- EBITDA Margin
- -258453.19%
- EBIT Margin
- -283142.55%
Analyst Forecast
The average price target for Sinew Pharma, Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- 16.46%
